baclofen sintetica 0,05 mg/ml roztwór do wstrzykiwań
sintetica gmbh - baclofenum - roztwór do wstrzykiwań - 0,05 mg/ml
baclofen sintetica 0,5 mg/ml roztwór do infuzji
sintetica gmbh - baclofenum - roztwór do infuzji - 0,5 mg/ml
baclofen sintetica 2 mg/ml roztwór do infuzji
sintetica gmbh - baclofenum - roztwór do infuzji - 2 mg/ml
olanzapine +pharma 5 mg tabletki
+pharma arzneimittel gmbh - olanzapinum - tabletki - 5 mg
olanzapine +pharma 10 mg tabletki
+pharma arzneimittel gmbh - olanzapinum - tabletki - 10 mg
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - okulistyka - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
ephedrini hydrochloridum sintetica 50 mg/ml roztwór do wstrzykiwań
sintetica gmbh - ephedrini hydrochloridum - roztwór do wstrzykiwań - 50 mg/ml
biorphen 10 mg/ml roztwór do wstrzykiwań
sintetica gmbh - phenylephrinum - roztwór do wstrzykiwań - 10 mg/ml
ephedrini hydrochloridum sintetica 10 mg/ml roztwór do wstrzykiwań
sintetica gmbh - ephedrini hydrochloridum - roztwór do wstrzykiwań - 10 mg/ml
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - okulistyka - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).